Venlafaxine Hydrochloride
NDC 54868-6127
Product Information
Venlafaxine Hydrochloride is a NDA-approved product labeled by Physicians Total Care, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a white product. This product entry covers the primary NDC 54868-6127 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
OS301
Code Structure Chart
Product Details
What is NDC 54868-6127?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- VENLAFAXINE HYDROCHLORIDE (UNII: 7D7RX5A8MO)
- VENLAFAXINE (UNII: GRZ5RCB1QG) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MANNITOL (UNII: 3OWL53L36A)
- POVIDONE (UNII: FZ989GH94E)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- POLYETHYLENE GLYCOL (UNII: 3WJQ0SDW1A)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- LACTOSE (UNII: J2B2A4N98G)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TRIACETIN (UNII: XHX3C3X673)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 808751 - venlafaxine HCl 37.5 MG 24HR Extended Release Oral Tablet
- RxCUI: 808751 - 24 HR venlafaxine 37.5 MG Extended Release Oral Tablet
- RxCUI: 808751 - venlafaxine 37.5 MG (as venlafaxine hydrochloride) 24 HR Extended Release Oral Tablet
- RxCUI: 808751 - venlafaxine 37.5 MG 24 HR Extended Release Oral Tablet
* Please review the full disclaimer at the bottom of this page.